journal article·2018-10-03Open access

Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications

Maryam Karimi-Jafari, Luis Padrela, Gavin M. Walker, Denise M. Croker

Crystal Growth & Design· Volume 18· Issue 10

Abstract

Originally discovered almost a century ago, cocrystals continue to gain interest in the modern day due to their\nability to modify the physical properties of solid-state materials, particularly pharmaceuticals. Intensification of cocrystal\nresearch efforts has been accompanied by an expansion of the potential applications where cocrystals can offer a benefit. Where\nonce solubility manipulation was seen as the primary driver for cocrystal formation, cocrystals have recently been shown to\nprovide attractive options for taste masking, mechanical property improvement, and intellectual property generation and\nextension. Cocrystals are becoming a commercial reality with a number of cocrystal products currently on the market and more\nfollowing in registration and clinical trial phases. Increased commercialization of cocrystals has in turn necessitated additional\nresearch on methods to make cocrystals, with particular emphasis placed on emerging technologies that can offer\nenvironmentally attractive and efficient options. Methods of producing cocrystals and of harnessing the bespoke physical\nproperty adjustment provided by cocrystals are reviewed in this article, with a particular focus on emerging trends in these areas.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · Energetic Materials and Combustion

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Synthesis & Solid State Pharmaceutical Centre (SSPC), Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland

Funding

Science Foundation Ireland

References (100+)

Show source-provided references
1. 10.1021/cg300294810.1021/cg3002948 ↗
2. 10.1039/C5CC08216A10.1039/C5CC08216A ↗
3. 10.1021/acs.molpharmaceut.5b0084310.1021/acs.molpharmaceut.5b00843 ↗
4. 10.1021/cg301088210.1021/cg3010882 ↗
5. Sekhon B. S. · International Journal of Agrochemicals and Plant Protection · 2014 · 2 · 44
6. 10.1039/c3ce41013g10.1039/c3ce41013g ↗
7. 10.1039/B904616J10.1039/B904616J ↗
8. 10.1021/cg500245e10.1021/cg500245e ↗
9. 10.1021/cg050125l10.1021/cg050125l ↗
10. 10.1021/cg060327x10.1021/cg060327x ↗
11. 10.1021/op300214p10.1021/op300214p ↗
12. 10.1517/17425247.2013.74750810.1517/17425247.2013.747508 ↗
13. 10.1016/j.apsb.2015.07.00310.1016/j.apsb.2015.07.003 ↗
14. 10.1016/j.addr.2016.04.02210.1016/j.addr.2016.04.022 ↗
15. 10.1016/j.addr.2017.03.00310.1016/j.addr.2017.03.003 ↗
16. 10.1021/cg901002y10.1021/cg901002y ↗
17. 10.3797/scipharm.cespt.8.PDD3310.3797/scipharm.cespt.8.PDD33 ↗
18. 10.1039/C6CE00353B10.1039/C6CE00353B ↗
19. 10.1021/mp200043u10.1021/mp200043u ↗
20. 10.1039/B812264D10.1039/B812264D ↗
21. 10.1039/C004371K10.1039/C004371K ↗
22. 10.1021/acs.molpharmaceut.5b0025010.1021/acs.molpharmaceut.5b00250 ↗
23. 10.1021/mp070009910.1021/mp0700099 ↗
24. 10.1021/cg401673z10.1021/cg401673z ↗
25. 10.1021/cg800764n10.1021/cg800764n ↗
26. 10.3109/03639045.2011.63326310.3109/03639045.2011.633263 ↗
27. 10.1021/cg049654010.1021/cg0496540 ↗
28. 10.1016/j.ejps.2010.08.01210.1016/j.ejps.2010.08.012 ↗
29. 10.1021/cg100099w10.1021/cg100099w ↗
30. 10.1021/cg101638810.1021/cg1016388 ↗
31. 10.1021/cg101609210.1021/cg1016092 ↗
32. 10.1021/acs.cgd.6b0176910.1021/acs.cgd.6b01769 ↗
33. 10.1021/cg800936d10.1021/cg800936d ↗
34. 10.1016/j.addr.2017.07.00110.1016/j.addr.2017.07.001 ↗
35. 10.1016/j.ejps.2016.02.01710.1016/j.ejps.2016.02.017 ↗
36. 10.1039/c0cc01195a10.1039/c0cc01195a ↗
37. 10.1039/C1CS15171A10.1039/C1CS15171A ↗
38. 10.1039/CT893630131410.1039/CT8936301314 ↗
39. 10.1007/BF0054035810.1007/BF00540358 ↗
40. Baláž P. · 2008 · 1
41. 10.1021/cg800764n10.1021/cg800764n ↗
42. 10.1039/b709411f10.1039/b709411f ↗
43. 10.1038/nmat184810.1038/nmat1848 ↗
44. 10.1039/b408971e10.1039/b408971e ↗
45. 10.1021/cg050168210.1021/cg0501682 ↗
46. 10.1002/chem.20070118410.1002/chem.200701184 ↗
47. 10.1021/cg800889310.1021/cg8008893 ↗
48. 10.1039/b801713c10.1039/b801713c ↗
49. 10.1021/mp800092t10.1021/mp800092t ↗
50. 10.1039/b400978a10.1039/b400978a ↗
51. 10.3390/pharmaceutics303058210.3390/pharmaceutics3030582 ↗
52. 10.1039/C3FD00153A10.1039/C3FD00153A ↗
53. 10.1080/0363904070152562710.1080/03639040701525627 ↗
54. 10.1002/jps.2194210.1002/jps.21942 ↗
55. 10.1016/j.ijpharm.2011.12.03310.1016/j.ijpharm.2011.12.033 ↗
56. 10.1039/C3CE42457J10.1039/C3CE42457J ↗
57. 10.1021/acs.cgd.6b0040210.1021/acs.cgd.6b00402 ↗
58. 10.1016/j.ijpharm.2015.07.02510.1016/j.ijpharm.2015.07.025 ↗
59. 10.1021/cg401375a10.1021/cg401375a ↗
60. 10.1007/s11095-010-0273-910.1007/s11095-010-0273-9 ↗
61. 10.1021/acs.molpharmaceut.6b0013410.1021/acs.molpharmaceut.6b00134 ↗
62. 10.1007/s11095-011-0605-410.1007/s11095-011-0605-4 ↗
63. 10.1016/j.ejpb.2013.04.02210.1016/j.ejpb.2013.04.022 ↗
64. 10.3390/cryst701001310.3390/cryst7010013 ↗
65. 10.1016/j.ejps.2014.06.01710.1016/j.ejps.2014.06.017 ↗
66. 10.1039/b818268j10.1039/b818268j ↗
67. 10.1016/j.tips.2012.12.00310.1016/j.tips.2012.12.003 ↗
68. 10.1039/C4CE01495B10.1039/C4CE01495B ↗
69. 10.1007/s11095-012-0709-510.1007/s11095-012-0709-5 ↗
70. 10.3390/cryst402012310.3390/cryst4020123 ↗
71. 10.1021/cg501310d10.1021/cg501310d ↗
72. 10.1021/cg500560w10.1021/cg500560w ↗
73. 10.1039/B813058B10.1039/B813058B ↗
74. 10.1016/j.ces.2015.01.04510.1016/j.ces.2015.01.045 ↗
75. 10.1016/j.jcrysgro.2014.02.00310.1016/j.jcrysgro.2014.02.003 ↗
76. 10.1021/mp050099m10.1021/mp050099m ↗
77. 10.1021/cg800632r10.1021/cg800632r ↗
78. 10.1002/jps.2243410.1002/jps.22434 ↗
79. 10.1021/op500145a10.1021/op500145a ↗
80. 10.1016/j.ejps.2009.05.01010.1016/j.ejps.2009.05.010 ↗
81. 10.1021/acs.cgd.5b0020010.1021/acs.cgd.5b00200 ↗
82. 10.1021/acs.cgd.5b0087610.1021/acs.cgd.5b00876 ↗
83. 10.1007/s11095-014-1498-910.1007/s11095-014-1498-9 ↗
84. 10.1208/s12249-012-9866-410.1208/s12249-012-9866-4 ↗
85. 10.1021/acs.oprd.5b0027910.1021/acs.oprd.5b00279 ↗
86. 10.1016/j.cej.2016.05.12910.1016/j.cej.2016.05.129 ↗
87. 10.1016/j.jcou.2015.11.00610.1016/j.jcou.2015.11.006 ↗
88. 10.1016/j.supflu.2010.01.01010.1016/j.supflu.2010.01.010 ↗
89. 10.1016/j.supflu.2013.12.01110.1016/j.supflu.2013.12.011 ↗
90. 10.1021/cg401131x10.1021/cg401131x ↗
91. 10.1021/acs.cgd.6b0028910.1021/acs.cgd.6b00289 ↗
92. 10.1039/C0CE00284D10.1039/C0CE00284D ↗
93. 10.1021/op400339910.1021/op4003399 ↗
94. Masters K. · 1985
95. 10.1007/s11095-007-9475-110.1007/s11095-007-9475-1 ↗
96. 10.1016/j.ejpb.2017.08.00510.1016/j.ejpb.2017.08.005 ↗
97. 10.1002/jps.260073020910.1002/jps.2600730209 ↗
98. 10.1021/cg100451q10.1021/cg100451q ↗
99. 10.1016/j.ejps.2014.06.00110.1016/j.ejps.2014.06.001 ↗
100. 10.1016/j.ijpharm.2017.12.02010.1016/j.ijpharm.2017.12.020 ↗